Transformation by v-Myb

Area of Science:

• Oncogenomics
• Virology
• Cancer Research History

Background:

• The avian myeloblastosis virus (AMV) causes acute leukemia in chickens, a disease model for human acute myelogenous leukemia.
• AMV's unique oncogene, v-myb, transforms only hematopoietic cells, distinguishing it from other oncogenic viruses like Rous sarcoma virus (RSV).
• Historically, AMV served as a crucial prototypic retrovirus for studying viral assembly and producing reverse transcriptase.

Purpose of the Study:

• To investigate the unique oncogenic properties of the v-myb gene in avian myeloblastosis virus (AMV).
• To understand the cellular origin and viral integration of the v-myb oncogene.
• To compare the genetic makeup of AMV with other avian leukemia viruses, such as E26 virus.

Main Methods:

• Analysis of viral oncogenes in acute leukemia viruses using techniques similar to those used for v-src.
• Molecular characterization of the AMV genome to identify sequences of cellular origin.
• Comparative genomic analysis of AMV and E26 virus.

Main Results:

• The v-myb oncogene in AMV was identified as a sequence of cellular origin, replacing most of the retroviral env gene.
• The v-myb oncogene sequences were found to be shared between AMV and E26 leukemia virus.
• E26 virus possesses a unique additional cellular sequence, ets, not found in other acutely transforming retroviruses.

Conclusions:

• The v-myb oncogene's cellular origin and specific tropism for hematopoietic cells highlight the diversity of oncogenic mechanisms.
• Comparative analysis reveals shared and unique genetic elements among avian leukemia viruses, contributing to understanding their oncogenic potential.
• AMV and E26 virus represent distinct but related models for studying viral oncogenesis and hematopoietic cell transformation.